Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Cost comparison of intravenous immunoglobulin and subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyneuropathy.

Muley SA, Gucciardi I, Kaisare V, Wissmann C, Bandy S, Yeh W-S, Myers L
J Med Econ. 2026 Dec; 29(1):2375-2385. PMID: 42764727. Abstract